Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 4, 2010, Pages 843-852

  Bryk, Jodie A ^a   Popovic, Petar J ^a   Zenati, Mazen S ^a   Munera, Veronica ^a   Pribis, John P ^a   Ochoa, Juan B ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Activated granulocytes; Arginine; Monocyte macrophage

Indexed keywords

ARGINASE 1; CD16 ANTIGEN; CD66B ANTIGEN; LYMPHOCYTE ANTIGEN; ORNITHINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLUNT TRAUMA; CELL ACTIVATION; CELL INFILTRATION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEGRANULATION; ENZYME ACTIVITY; FEMALE; GRANULOCYTE; GUNSHOT INJURY; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ARGINASE; BLOTTING, WESTERN; FEMALE; FLOW CYTOMETRY; HUMANS; INJURY SEVERITY SCORE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYELOID CELLS; WOUNDS AND INJURIES;

EID: 77951065769     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181b026e4     Document Type: Article

References (35)

1. Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB. CD11b/Gr-1 myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol. 2006;176:2085-2094.
2. Ochoa JB, Bernard AC, O'Brien WE, et al. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg. 2001;233: 393-399.
3. Tsuei BJ, Bernard AC, Shane MD, et al. Surgery induces human mononuclear cell arginase I expression. J Trauma. 2001;51:497-502.
4. Munder M, Mollinedo F, Calafat J, et al. Arginase I is constitutively expressed in human granulocyte and participates in fungicidal activity. Blood. 2005;105:2549-2566.
5. Munder M, Schneider H, Luckner C, et al. Suppression of T-cell functions by human granulocyte arginase. Blood. 2006;108:1627-1634.
6. Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 2001;61:4756-4760.
7. Goddard DS, Yamanaka K, Kupper TS, Jones DA. Activation of neutrophils in cutaneous T-cell lymphoma. Clin Cancer Res. 2005;11:8243-8249.
8. Strober W. Isolation and functional analysis of neutrophils. In: Coligan JE, Kruisbeck AM, Margulies DH, Shevach EM, Strober W, eds. Current protocols in immunology. New York, NY: Green-Wiley Interscience; 1994, 7:7.23.
9. Konarska L, Tomaszewski L. A simple quantitative micromethod or arginase assay in blood spots dried on filter paper. Clin Chim Acta. 1986;154:7-17.
10. Bradford M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1992;72:248-254.
11. Lazarus HM, Fox J, Lloyd JF, et al. A six-year descriptive study of hospital-associated infection in trauma patients: demographics, injury features, and infection patterns. Surg Infect. 2007;8:463-473.
12. Papia G, McLellan BA, El-Helou P, et al. Infection in hospitalized trauma patients: incidence, risk factors, and complications. J Trauma. 1999;47:923-927.
13. Jamulitrat S, Narong MN, Thongpiyapoom S. Trauma severity scoring systems as predictors of nosocomial infection. Infect Control Hosp Epidemiol. 2002;23:268-273.
14. Popovic PJ, Zeh HJ III, Ochoa JB. Arginine and immunity. J Nutr. 2007;137:1681S-1686S.
15. Osunkoya BO, Adler WH, Smith RT. Effect of arginine deficiency on synthesis of DNA and immunoglobulin receptor of Burkitt lymphoma cells. Nature. 1970;227:398-399.
16. Ochoa JB, Strange J, Kearney P, Gellin G, Endean E, Fitzpatrick E. Effects of L-arginine on the proliferation of T lymphocyte subpopulations. JPEN J Parenter Enteral Nutr. 2001;25:23-29.
17. Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC. Regulation of T cell receptor CD3 zeta chain expression by L-arginine. J Biol Chem. 2002;277:21123-21129.
18. De AK, Kodys KM, Pellegrini J, et al. Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression. Clin Immunol. 2000;96:52-66.
19. Ichihara F, Kono K, Sekikawa T, Matsumoto Y. Surgical stress induces decreased expression of signal-transducing zeta molecules in T cells. Eur Surg Res. 1999;31:138-146.
20. Rodriguez PC, Quiceno DG, Zabaleta J, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 2004;64:5839-5849.
21. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991;214:621-626.
22. Chiarla C, Giovannini I, Siegel JH. Plasma arginine correlations in trauma and sepsis. Amino Acids. 2006;30:81-86.
23. Shi HP, Wang SM, Zhang GX, Zhang YJ, Barbul A. Supplemental L-arginine enhances wound healing following trauma/hemorrhagic shock. Wound Repair Regen. 2007;15:66-70.
24. Beale R, Bryg D, Bihari D. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999;27:2799-2805.
25. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286:944-953.
26. Kudsk KA, Minard G, Croce MA, et al. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg. 1996;224:531-540.
27. Daly J, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg. 1988;208:512-523.
28. Tepaske R, Velthuis H, Oudemans-van Straaten HM, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebocontrolled trial. Lancet. 2001;358:696-701.
29. Bistrian BR. Practical recommendations for immune-enhancing diets. J Nutr. 2004;134:2868S-2872S.
30. Kudsk KA. Immunonutrition in surgery and critical care. Annu Rev Nutr. 2006; 26:463-479.
31. Lovett JE III, Fink BF, Bernard A, Ochoa J. Analysis of nitric oxide activity in prevention of reperfusion injury. Ann Plast Surg. 2001;46:269-273.
32. de Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R. Clinical and biochemical outcomes after a randomized trial with a high dose of enteral arginine formula in postsurgical head and neck cancer patients. Eur J Clin Nutr. 2007;61:200-204.
33. Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery. 1992;112:56-67.
34. von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci. 1991;88:7538-7542.
35. Kinhult J, Egesten A, Benson M, Uddman R, Cardell LO. Increased expression of surface activation markers on neutrophils following migration into the nasal lumen. Clin Exp Allergy. 2003; 33:1141-1146.